Last week, I waxed rhapsodic about why we wrench (the joy of solving problems, making choices, doing things our own way, ...

Week 3 is behind us, and now it's time to start focusing on Week 4 and beyond. That starts with the waiver wire. After a rash of injuries this weekend, this is going to be a huge week for running ...

Week 3 of the Fantasy Football season is always a very telling one as we get through the Week 1 and 2 overreactions and sift through more data on how each offense plans to utilize their personnel. Our ...

Be careful with single-phase motors, as most single-phase motors have components to help them start or continue to run ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...

The Houston Texans are releasing the starting safety, NFL Network Insider Ian Rapoport reported, per sources informed of the situation. The team later announced Gardner-Johnson's departure. Houston ...

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's disease candidate from its Brainshuttle programme, a technology designed to help ...

Thanks for standing by, and welcome to the Syntara Investor Webinar following the company's announcement today of top line data from its Phase IIa clinical trial of amsulostat to treat myelofibrosis ...

Fork, meet the 2025 Houston Texans. Coming into the year, the franchise stood as the betting favorite to win the AFC South once again, claiming the division for what would be the third consecutive ...

Stood by his side on the red carpet of the Icon Awards, Eamonn Holmes' girlfriend was all smiles for the waiting photographers while placing a loving hand on his back. Meanwhile the GB News presenter ...

As previously reported, H.C. Wainwright downgraded IO Biotech (IOBT) to Neutral from Buy with no price target after the company gave an update from its pre-BLA meeting with the FDA and reported that ...